Filing Details

Accession Number:
0000950170-24-139124
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-12-20 17:00:06
Reporting Period:
2024-12-18
Accepted Time:
2024-12-20 17:00:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1789972 Cullinan Therapeutics Inc. CGEM Biological Products, (No Disgnostic Substances) (2836) 813867811
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1914647 Alan Jeffrey Jones C/O Cullinan Therapeutics, Inc.
One Main Street, Suite 1350
Cambridge MA 02142
Chief Medical Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-12-18 4,632 $11.41 114,059 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.